[Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with the focus on rheumatoid arthritis. Integration of a systematic literature research with the expert opinion of a large international panel of rheumatologists within the framework of the 3e initiative].
Tarner
I H
IH
Lehrstuhl für Innere Medizin mit Schwerpunkt Rheumatologie, Justus-Liebig-Universität Giessen, Abteilung für Rheumatologie und klinische Immunologie, Kerckhoff-Klinik, Benekestrasse 2-8, 61231 Bad Nauheim, Deutschland. ingo.h.tarner@innere.med.uni-giessen.de
Müller-Ladner
U
U
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007231:Infant, Newborn; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D012307:Risk Factors
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D008727:Methotrexate